| Retail Pharmacy Chain | Private label generic medicines, OTC and ayurvedic products via company-owned and franchise stores. | Largest private chain with strong brand, asset-light franchise model, exclusive products, and increasing consumer trust. | B2C consumers across India, focusing on chronic disease patients. | Private-label chronic medicines and OTC products. | 186 | 64 | Product sales through retail stores, franchises, and online platform with doorstep delivery. | Discounted pricing 30%-90% less than branded equivalents; franchise fee and product margins. | Rapid store network expansion, increased generic drug acceptance, chronic therapy focus, and online sales platform. | Davaindia |
| Domestic Marketing | Distribution of finished dosage forms sourced from WHO-GMP manufacturers through network of 1050+ distributors. | Large distributor network with quality-assured product portfolio from trusted manufacturers. | B2B distribution to pharmacies and medical outlets in India. | Ethically marketed generic formulations. | 63 | 22 | Sales revenue from wholesale distribution across various Indian states. | Wholesale bulk sales with distributor incentives. | Increasing generic drug adoption and expanding domestic distribution footprint. | Zota branded generics and OTC products |
| Exports | Manufacture and export of 250+ formulations to 30+ countries in Africa, Asia, CIS, and Latin America. | Strong regulatory dossier pipeline, WHO-GMP manufacturing site, and diversified export markets. | International semi-regulated and regulated markets, government and private buyers. | Contract manufacturing and regulated market sales. | 32 | 11 | Export sales and contract manufacturing revenue. | Bulk export contracts and regulatory registrations. | Expanded regulatory approvals and dossier filings; growing international demand for generics. | Various generic formulations |
